Acquired resistance to everolimus in aromatase inhibitor-resistant breast cancerMariko Kimura(Kobe Women's University), Shin‐ichi Hayashi(Tohoku University)OncotargetApril 20, 201810.18632/oncotarget.25133Cited by 15SaveCiteExport RISWatch citationsRelated PapersThe p21 levels have the potential to be a monitoring marker for ribociclib in breast cancer|Oncotarget|2019|33